IIT Bombay, 20-21 March 2026
This event aims to bring together academic leaders, policymakers, clinicians, and industry experts to reflect on past successes and chart the future of biomedical innovation. Through keynote talks, panel discussions, and roundtable sessions, the programme will explore the science, translation, and equitable access of next-generation therapeutics—spanning antibodies, cell and gene therapies, emerging oncology modalities, AI-driven drug design, and manufacturing insights—while positioning India’s role in shaping the global therapeutic landscape.
Our sponsors
Registration
Registrations are now open. We cordially invite you to complete the registration process to participate in the event. Accommodation is not provided.
Postdoctoral fellows, PhD/Bachelors/Masters students & Project staff (IIT Bombay & other institutions): INR 1,500
Faculty (Institutes/Universities excluding IIT Bombay): INR 2,500
Industry / Startups / Others: INR 5,000
Last date for registration: 16 March 2026
Speakers
Dr. Sanjay Singh
CEO, Gennova Biopharmaceuticals
Dr. Ravi Kannan R
Surgical oncologist
Cachar Cancer Hospital and Research Centre
Dr. Akhilesh Sharma
President, CMO, Alkem Laboratories
Dr. Shirshendu Mukherjee
MD & CEO, WIN
Wadhwani Foundation
Prof. Jayanta Bhattacharya
Dean, THSTI
Mr. Gautam Khanna
CEO, Hinduja Hospital
Dr. Murali Ramachandra
CEO, Aurigene Oncology
Dr. Narendra Chirmule
CEO, Director, Co-Founder, SymphonyTech Biologics, Visiting Professor-IITB
Dr. Prashant Agrawal
Chief Scientific Officer at Datar Cancer Genetics Limited
Dr. Sujata Mohanty
Professor, Stem Cell Facility, All India Institute of Medical Sciences
Dr. Maneesh Paul
Founder
Microvioma
Dr. Mahesh Bhalgat
MD and Group CEO, Veeda Lifesciences
Dr. Abdur Rub
CEO, ITRI
Dr. Avinash Desai
CSO, Amneal Pharmaceuticals
Dr. Jayashree Aiyar
CSO, Syngene International Ltd
Mr. B. N. Manohar
MD & CEO, Stempeutics Research
Dr. Kamini Walia
Senior Scientist
ICMR
Dr. Anita Krishnan
Associate Vice President
Biocon Biologics
Dr. Rajappa Tadepalli
Chief Executive Officer
IITB Aspire
Dr. Shalabh Malik
Technical Director, Dr. Lal PathLabs
Dr. Vaijayanti Gupta
CSO, CrisprBits
Dr. Lakshmikanth Gandikota
CSO, Immuneel Therapeutics
Dr. Saurabh Joshi
SunPharma
Dr. Jugnu Jain
CEO, Sapien Biosciences
Dr. Vadiraja Bhat
Head – Market Development, SCIEX India
Dr. Vijay Patil
Cofounder, SunACT
Dr. Reshmi Nair
Director, Syngene International
Dr. Sujata Haldar
VP, Zydus Research Centre, Ahmedabad
Dr. Nikhil Jain
Director, Syngene International Ltd.
Dr. Prabuddha Kundu
Cofounder and Director, Premas Technologies
Dr. Anirban Mudi
Lead Platform Product Manager, Data & AI Strategy, Danaher IDBS
Prof. Jayandharan G. Rao
Biological Sciences & Bioengineering, IIT Kanpur
Kavitha Iyer Rodrigues
Founder, CEO, Zumutor Biologics
Prof. Rahul Purwar, IIT Bombay
Founder, ImmunoACT
Navratna Vajpai
CEO, WITC
Dr. Amol Patel
Medical Oncologist
Army Medical College
Dr. Prasad Bhukebag
Visiting surgeon, IIT Bombay
Zen Multispecialty Hospital
Dr. Aditya Kulkarni
CSO
Avammune Therapeutics
Dr. Soumil Vyas
Surgical Oncologist
Sir H. N. Reliance Foundation Hospital
Dr. Bharat Somani
Internal Medicine
Hinduja Hospital
Dr. Jyotirmoi Aich
DGM, Meril
Mr. Arul Mehra
Partner-Baring Private Equity India
Dr. Arkasubhra Ghosh
Chief Scientist, Narayana Nethralaya Eye Hospital
Dr. Vishal Warke
Director (R&D), HiMedia Laboratories
Prof. Debjani Paul
Biosciences & Bioengineering IIT Bombay
Prof. Samir Maji
Biosciences & Bioengineering IIT Bombay
Prof. Ashutosh Kumar
Professor-in-charge
WITC & WRCB
Prof. Prakriti Tayalia
Biosciences & Bioengineering IIT Bombay